Application of Chitin and Chitosan Derivatives in the Pharmaceutical Field
Применение производных хитина и хитозана в фармацевтической области
2003-10-01
SCID: 54.1/vdcwtd9x
Discuss with AI
chitosan derivativesdrug carriersmucosal drug deliverysustained drug releasewound dressings
Figures from the paper
Abstract (AI)
Chitin and chitosan derivatives are used as excipients and drug carriers in the pharmaceutical field. Their derivatization contributed to expansion of application and decrease toxicity. Chitosan is used as an excipient in oral dosage form. Chitosan tablet can exhibit a sustained drug release compared to commercial products. Films prepared using chitin or chitosan have been developed as wound dressings, oral mucoadhesive and water-resisting adhesive by virtue of their release characteristics and adhesion. Intratumoral administration of gadopentetic acid-chitosan complex nanoparticles (approximately 430 nm in diameter) has been more effective for gadolinium neutron-capture therapy compared with a group treated with the solution. Compared to intragastrical feeding with diphtheria toxoid (DT) in PBS, a strong enhancement of the systemic (IgG) and local (IgA) immune responses against DT has been observed in mice fed with DT loaded chitosan microparticles (approximately 4.7 microm in size). When DNA-loaded chitosan microspheres (1.15 - 1.28 microm) were intramuscularly administrated into mice, high beta-galactosidase and luciferase productions were obtained even after a long post-transfection period (12 weeks). N-Succinyl-chitosan (Suc-Chi) has been studied for cancer chemotherapy as a drug carrier and the conjugates of mitomycin C with Suc-Chi exhibited good antitumor activities against various tumors. Furthermore, trimethyl-chitosan and monocarboxymethyl-chitosan has been shown to be effective as intestinal absorption enhancers due to their physiological properties. Chitosan-thioglycolic acid conjugates has been found to be a promising candidate as scaffold material in tissue engineering due to their physicochemical properties. This review summarizes the application of chitin and chitosan derivatives for hospital preparations and drug carriers.
Key Findings
1
Chitin and chitosan derivatization expands pharmaceutical applications while reducing toxicity, supporting their use as excipients and drug carriers.
2
Chitosan microparticles approximately 4.7 micrometers in size enhanced systemic IgG and local IgA responses to orally administered diphtheria toxoid in mice.
3
Chitosan tablets can provide sustained drug release compared with commercial products, while chitin- or chitosan-based films support wound dressing and mucoadhesive applications.
4
DNA-loaded chitosan microspheres approximately 1.15–1.28 micrometers in size produced high beta-galactosidase and luciferase expression for up to 12 weeks after intramuscular administration.
5
Intratumoral gadopentetic acid–chitosan nanoparticles approximately 430 nm in diameter improved gadolinium neutron-capture therapy compared with the corresponding solution.
6
N-Succinyl-chitosan drug conjugates showed good antitumor activity, while trimethyl-chitosan and monocarboxymethyl-chitosan enhanced intestinal absorption and chitosan-thioglycolic acid conjugates showed promise for tissue-engineering scaffolds.
Research Object
Chitin, chitosan, and their derivatives used in pharmaceutical applications
Research Subject
Their pharmaceutical functions and performance as excipients, drug carriers, delivery systems, absorption enhancers, wound-dressing and adhesive films, and tissue-engineering scaffolds
Publication Details
Publication Date
2003-10-01
Journal
Publisher
ISSN
Cited by
297
Access Type
Author Information
Download PDF
Subscribe to digest